Skip to Content

Medicines, Volume 8, Issue 1

2021 January - 6 articles

Cover Story: Primary small cell carcinoma of the kidney (PSCCK) is an exceedingly rare disease, though recent advances in laboratory diagnosis and practice trends stand to increase its observed incidence, underscoring the need to familiarize clinicians with this aggressive malignancy. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Article
  • Open Access
3 Citations
4,945 Views
10 Pages

Primary Small Cell Carcinoma of the Kidney: Disease Characteristics and Treatment Outcomes

  • Thomas F. Monaghan,
  • Kyle P. Michelson,
  • Nicholas R. Suss,
  • Christina W. Agudelo,
  • Syed N. Rahman,
  • Dennis J. Robins,
  • Viktor X. Flores,
  • Brian K. McNeil,
  • Jeffrey P. Weiss and
  • Andrew G. Winer

Background: Primary small cell carcinoma of the kidney (PSCCK) is exceedingly rare and data on disease characteristics and outcomes are sparse. This study examines a nationally-representative cancer registry to better characterize PSCCK. Methods: We...

(This article belongs to the Section Nephrology and Urology)
  • Case Report
  • Open Access
3 Citations
4,248 Views
4 Pages

Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report

  • Maria Massucci,
  • Veronica Mollica,
  • Alessandro Rizzo,
  • Laura Ventrella,
  • Ilaria Maggio,
  • Lisa Manuzzi,
  • Lidia Gatto,
  • Giovanni Brandi and
  • Francesco Massari

Renal cell carcinoma is a malignant tumor that arises in the kidney parenchyma. For many years, sunitinib has represented the mainstay of medical treatment for metastatic renal cell carcinoma. Herein, we present the case of a 66-year-old woman with m...

  • Review
  • Open Access
25 Citations
22,615 Views
12 Pages

Neurogenic Erectile Dysfunction. Where Do We Stand?

  • Charalampos Thomas and
  • Charalampos Konstantinidis

Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrin...

  • Article
  • Open Access
28 Citations
7,272 Views
14 Pages

Background: Acute kidney injury (AKI) is a serious complication of COVID-19. Methods: Records of hospitalized adult patients with confirmed SARS-CoV-2 infection from 1 March to 31 May 2020 were retrospectively reviewed. Results: Of 283 patients, AKI...

(This article belongs to the Section Nephrology and Urology)
  • Review
  • Open Access
13 Citations
10,643 Views
8 Pages

Erectile Dysfunction Treatment Using Stem Cells: A Review

  • Vassilis Protogerou,
  • Dimosthenis Chrysikos,
  • Vasileios Karampelias,
  • Ypatios Spanidis,
  • Sara El Bisari and
  • Theodoros Troupis

Erectile dysfunction (ED) is a disorder that affects the quality of life and the sexual relations of more than half of the male population aged over 40 years. The prediction regarding the incidence of ED is devastating as it is expected that this dis...

  • Article
  • Open Access
9 Citations
7,575 Views
17 Pages

Predictive Effect of Helicobacter pylori in Gastric Carcinoma Development: Systematic Review and Quantitative Evidence Synthesis

  • Laurens Holmes,
  • Jasmine Rios,
  • Betyna Berice,
  • Jacqueline Benson,
  • Nastocia Bafford,
  • Kadedrah Parson and
  • Daniel Halloran

Helicobacter pylori (H. pylori) is a bacterial pathogen implicated in gastritis, gastric ulceration, and gastric carcinoma. This study aimed to synthesize literature in providing evidence on the causative role of H. pylori in gastric carcinoma develo...

(This article belongs to the Section Cancer Biology and Anticancer Therapeutics)
XFacebookLinkedIn
Medicines - ISSN 2305-6320